Pfizer

CFOs On the Move: Week Ending November 19
Frank D’Amelio to Step Down as Pfizer CFO
Merck Drops Out of COVID-19 Vaccine Race
Early Analysis Shows Pfizer COVID-19 Vaccine 90% Effective
Pfizer, BioNTech to Supply U.S. Government Up to 600M Doses of Coronavirus Vaccine
Pfizer and Mylan to Combine Off-Patent Drugs Businesses
Pfizer Beats Estimates on Strength in Key Drugs
Pfizer to Split Into Three Units
Pfizer Q4 Profit Surges to $12B But Shares Fall
Generic Competition Hits Pfizer’s Q2 Sales
What Makes for a Public-Company CFO?
Pfizer Makes Cancer Play With Medivation Deal
Ex-Pfizer Employee Accused of Insider Trading
Pfizer Adds Eczema Gel With $5B Anacor Deal
Finance Roundup for Executives